The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the f
-
Paragraph 0416; 0417
(2015/05/26)
NITROGENATED HETEROCYCLIC COMPOUND
The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.
-
Paragraph 0585; 0868
(2015/03/28)
SYNTHESES OF FUNCTIONALIZED N-(2-PYRIDYL)-α-AMINO ACIDS AND ESTERS BY RING OPENING OF IMIDAZOPYRIDINE
This report is devoted to the ring opening of the imidazole nucleus of functionalized imidazopyridines, by methanol in strong acid medium (HClO4) leading to esters of N-(2-pyridyl)-α-amino acids in which the heterocyclic moiety bears a functional g
Doise, Muriel,Blondeau, Dominique,Sliwa, Henri
p. 2079 - 2093
(2007/10/02)
More Articles about upstream products of 146294-95-3